| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |